Cargando…
MicroRNA-939 Directly Targets HDGF to Inhibit the Aggressiveness of Prostate Cancer via Deactivation of the WNT/β-Catenin Pathway [Retraction]
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Dove
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502062/ https://www.ncbi.nlm.nih.gov/pubmed/34675543 http://dx.doi.org/10.2147/OTT.S341951 |
| _version_ | 1784580805959352320 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8502062 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Dove |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85020622021-10-20 MicroRNA-939 Directly Targets HDGF to Inhibit the Aggressiveness of Prostate Cancer via Deactivation of the WNT/β-Catenin Pathway [Retraction] Onco Targets Ther Retraction Dove 2021-10-05 /pmc/articles/PMC8502062/ /pubmed/34675543 http://dx.doi.org/10.2147/OTT.S341951 Text en © 2021 Dove Medical Press. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
| spellingShingle | Retraction MicroRNA-939 Directly Targets HDGF to Inhibit the Aggressiveness of Prostate Cancer via Deactivation of the WNT/β-Catenin Pathway [Retraction] |
| title | MicroRNA-939 Directly Targets HDGF to Inhibit the Aggressiveness of Prostate Cancer via Deactivation of the WNT/β-Catenin Pathway [Retraction] |
| title_full | MicroRNA-939 Directly Targets HDGF to Inhibit the Aggressiveness of Prostate Cancer via Deactivation of the WNT/β-Catenin Pathway [Retraction] |
| title_fullStr | MicroRNA-939 Directly Targets HDGF to Inhibit the Aggressiveness of Prostate Cancer via Deactivation of the WNT/β-Catenin Pathway [Retraction] |
| title_full_unstemmed | MicroRNA-939 Directly Targets HDGF to Inhibit the Aggressiveness of Prostate Cancer via Deactivation of the WNT/β-Catenin Pathway [Retraction] |
| title_short | MicroRNA-939 Directly Targets HDGF to Inhibit the Aggressiveness of Prostate Cancer via Deactivation of the WNT/β-Catenin Pathway [Retraction] |
| title_sort | microrna-939 directly targets hdgf to inhibit the aggressiveness of prostate cancer via deactivation of the wnt/β-catenin pathway [retraction] |
| topic | Retraction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502062/ https://www.ncbi.nlm.nih.gov/pubmed/34675543 http://dx.doi.org/10.2147/OTT.S341951 |